Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Neoplasms 6Colonic Neoplasms 3Urinary Bladder Neoplasms 2Respiratory Aspiration 2Prostatic Neoplasms 2Uterine Neoplasms 1Thyroid Neoplasms 1Rectal Neoplasms 1Quality of Recovery 1Postoperative Complications 1Postoperative Cognitive Complications 1Pituitary Neoplasms 1Neurofibromatoses 1Myofibroma 1Melanoma 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Inflammation 1Hypoxia 1Hydrocephalus 1Headache 1Female Breast Carcinoma 1Epilepsy 1Endoplasmic Reticulum Stress 1Delirium 1Cough 1Abdominal Neoplasms 1

Interventions

remimazolam 1Sevoflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Quality of Recovery × Sevoflurane × Clear all
NCT05356091 2023-03-09

Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.

Kangbuk Samsung Hospital

Phase NA Completed
36 enrolled

Quality of Recovery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡